文献
J-GLOBAL ID:202202272270842109
整理番号:22A0800412
未治療の慢性リンパ球性白血病患者における健康関連QOLと症状の改善:オビヌツズマブとベンダムスチンの併用の第II相GIBB研究の最終結果【JST・京大機械翻訳】
Improvements in Health-related Quality of Life and Symptoms in Patients With Previously Untreated Chronic Lymphocytic Leukemia: Final Results From the Phase II GIBB Study of the Combination of Obinutuzumab and Bendamustine
著者 (10件):
Danilov Alexey V.
(Department of Hematology and Hematopoietic Stem Cell Transplant, Toni Stephenson Lymphoma Center, City of Hope Comprehensive Cancer Center, Duarte, CA)
,
Yimer Habte A.
(US Oncology Research-Texas Oncology, Tyler, TX)
,
Boxer Michael A.
(Arizona Oncology, Tucson, AZ)
,
Burke John M.
(Rocky Mountain Cancer Centers & US Oncology, Aurora, CO)
,
Babu Sunil
(Division of Clinical Research, Fort Wayne Medical Oncology & Hematology & US Oncology, Fort Wayne, IN)
,
Li Jia
(US Medical Affairs, Genentech, Inc., South San Francisco, CA)
,
Mun Yong
(US Medical Affairs, Genentech, Inc., South San Francisco, CA)
,
Trask Peter C.
(Patient-Centered Outcomes Research, Genentech, Inc., South San Francisco, CA)
,
Masaquel Anthony S.
(US Medical Affairs, Genentech, Inc., South San Francisco, CA)
,
Sharman Jeff P.
(Department of Medical Oncology, Willamette Valley Cancer Institute and Research Center & US Oncology, Eugene, OR)
資料名:
Clinical Lymphoma Myeloma and Leukemia
(Clinical Lymphoma Myeloma and Leukemia)
巻:
22
号:
2
ページ:
121-128
発行年:
2022年
JST資料番号:
W3263A
ISSN:
2152-2650
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)